Published on
March 5, 2026
- 11:52 GMT
Stellarix Webinar Examines Strategic Pathways for F&B Industry to Navigate the GLP-1 Disruption
NEW YORK, NY, UNITED STATES, March 5, 2026 /EINPresswire.com/ -- GLP-1 medications are gradually moving beyond clinics. Once considered ideal for type 2 diabetes, this drug is now analogous to weight management. This interdisciplinary rise is also …
Distribution channels:
Food & Beverage Industry
...
